Speaker
Chief Technical Officer, Tr1x therapeutics
James Adams, Chief Technical Officer at Tr1x therapeutics, appears in the programmes of 2 conferences on kongre.net. Most recently: 3rd Raw Materials for Cell & Gene Therapy Summit (San Diego, United States of America, 26–28 Oct 2026).
26–28 Oct 2026San Diego, United States of America
15–17 Sept 2026Boston, United States of America
Associate Director, MS&T, Ray Therapeutics
Associate Director, Raw Materials, Drug Product Process Development, Bristol Myers Squibb
Director, Analytical Development, Astellas Pharma
Technical Development Scientist II, Genentech
Senior Scientist, Global Biologics, U.S. Pharmacopeia
Independent Raw Materials Expert & USP CGT Expert Committee Member, Independent Expert
Executive Director, Analytical Strategy, Cell Therapy Global Quality, Bristol Myers Squibb
Vice President, Immunology, Sail Biomedicines
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca
Chief Technology Officer, Anocca AB
Chief Business Development Officer, PolTREG
Senior Director, Oncology Scientific Innovation, Johnson & Johnson
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by James Adams, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].